HUP9903679A3 - Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder - Google Patents

Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder

Info

Publication number: HUP9903679A3
Authority: HU; Hungary
Prior art keywords: olanzapine; preparation; pharmaceutical compositions; bipolar disorder; treating bipolar
Prior art date: 1996-03-11

Application number

HU9903679A

Other languages

Hungarian (hu)

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-11

Filing date

1996-12-04

Publication date

2001-10-29

1996-12-04 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2000-04-28 Publication of HUP9903679A2 publication Critical patent/HUP9903679A2/en

2001-10-29 Publication of HUP9903679A3 publication Critical patent/HUP9903679A3/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)

HU9903679A 1996-03-11 1996-12-04 Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder HUP9903679A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US1315996P	1996-03-11	1996-03-11

Publications (2)

Publication Number	Publication Date
HUP9903679A2 HUP9903679A2 (en)	2000-04-28
HUP9903679A3 true HUP9903679A3 (en)	2001-10-29

Family

ID=21758606

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU9903679A HUP9903679A3 (en)	1996-03-11	1996-12-04	Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder

Country Status (15)

Country	Link
EP (1)	EP0889725A4 (en)
JP (1)	JP2000506859A (en)
KR (1)	KR19990087713A (en)
CN (1)	CN1213966A (en)
AU (1)	AU734011B2 (en)
BR (1)	BR9612548A (en)
CZ (1)	CZ290298A3 (en)
EA (1)	EA000758B1 (en)
HU (1)	HUP9903679A3 (en)
IL (1)	IL126162A0 (en)
NO (1)	NO984189L (en)
NZ (1)	NZ326031A (en)
PL (1)	PL328925A1 (en)
TR (1)	TR199801797T2 (en)
WO (1)	WO1997033577A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6960577B2 (en)	1998-05-22	2005-11-01	Eli Lilly And Company	Combination therapy for treatment of refractory depression
IL139592A (en) *	1998-05-22	2005-08-31	Lilly Co Eli	Pharmaceutical composition containing an atypical antipsychotic and a serotonin reuptake inhibitor for combination therapy of refractory depression
WO1999062522A1 (en) *	1998-05-29	1999-12-09	Eli Lilly And Company	Combination therapy for treatment of bipolar disorders
ATE286398T1 (en)	1998-11-23	2005-01-15	Sepracor Inc	COMPOSITIONS AND METHODS CONTAINING DESMETHYLOLANZAPINE
CA2351719A1 (en) *	1998-11-23	2000-06-02	Sepracor Inc.	Pharmaceutical compositions containing olanzapine-n-oxide
JP2002530339A (en)	1998-11-23	2002-09-17	セプラコール，インク．	2-Hydroxymethylolanzapine compositions and methods
JP6440625B2 (en)	2012-11-14	2018-12-19	ザ・ジョンズ・ホプキンス・ユニバーシティー	Methods and compositions for treating schizophrenia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5229382A (en) *	1990-04-25	1993-07-20	Lilly Industries Limited	2-methyl-thieno-benzodiazepine
US5457101A (en) *	1994-06-03	1995-10-10	Eli Lilly And Company	Thieno[1,5]benzoidiazepine use

1996
- 1996-12-04 EA EA199800819A patent/EA000758B1/en not_active IP Right Cessation
- 1996-12-04 AU AU13307/97A patent/AU734011B2/en not_active Ceased
- 1996-12-04 EP EP96944772A patent/EP0889725A4/en not_active Withdrawn
- 1996-12-04 CZ CZ982902A patent/CZ290298A3/en unknown
- 1996-12-04 WO PCT/US1996/019575 patent/WO1997033577A1/en not_active Application Discontinuation
- 1996-12-04 IL IL12616296A patent/IL126162A0/en unknown
- 1996-12-04 PL PL96328925A patent/PL328925A1/en unknown
- 1996-12-04 NZ NZ326031A patent/NZ326031A/en unknown
- 1996-12-04 BR BR9612548A patent/BR9612548A/en not_active Application Discontinuation
- 1996-12-04 CN CN96180183A patent/CN1213966A/en active Pending
- 1996-12-04 JP JP9532570A patent/JP2000506859A/en active Pending
- 1996-12-04 TR TR1998/01797T patent/TR199801797T2/en unknown
- 1996-12-04 HU HU9903679A patent/HUP9903679A3/en unknown
- 1996-12-04 KR KR1019980707180A patent/KR19990087713A/en not_active Application Discontinuation
1998
- 1998-09-11 NO NO984189A patent/NO984189L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
NZ326031A (en)	2001-05-25
EA199800819A1 (en)	1999-02-25
AU1330797A (en)	1997-10-01
NO984189D0 (en)	1998-09-11
EP0889725A4 (en)	2000-01-19
PL328925A1 (en)	1999-03-01
JP2000506859A (en)	2000-06-06
HUP9903679A2 (en)	2000-04-28
CN1213966A (en)	1999-04-14
TR199801797T2 (en)	1998-12-21
KR19990087713A (en)	1999-12-27
BR9612548A (en)	1999-07-20
CZ290298A3 (en)	1999-10-13
EP0889725A1 (en)	1999-01-13
EA000758B1 (en)	2000-04-24
AU734011B2 (en)	2001-05-31
IL126162A0 (en)	1999-05-09
WO1997033577A1 (en)	1997-09-18
NO984189L (en)	1998-09-11

Similar Documents

Publication	Publication Date	Title
IL125735A0 (en)	1999-04-11	Pharmaceutical compositions for the treatment of glaucoma
HUP0103856A3 (en)	2003-11-28	Pharmaceutical composition for the treatment of acute disorders
HUP0001607A3 (en)	2002-09-30	Thienopyrimidine derivatives, pharmaceutical compositions containing them, process for their preparation and use of the compounds
IL119833A0 (en)	1997-03-18	Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis
HUP0102556A3 (en)	2002-12-28	Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds
HUP9903489A3 (en)	2001-12-28	Use of epinastine for the preparation of pharmaceutical compositions treating pain
HUP9700328A3 (en)	1998-09-28	Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates
EP0943327A4 (en)	2003-06-25	Medicinal composition
HUP0003851A3 (en)	2002-10-28	Pharmaceutical composition for the treatment or prevention of glomerulopathy
AP2000002010A0 (en)	2000-12-31	Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
HUP9900886A3 (en)	2002-04-29	Use of bisphosphonates preventing bone loss associated with immunosuppressive therapy for the preparation of pharmaceutical compositions
GB2311940B (en)	2000-07-19	Pharmaceutical compositions for the treatment of rhinitis
HUP9901326A3 (en)	2000-12-28	Benzopyran derivatives having leukotriene-antagonistic action, pharmaceutical compositions containing these compounds, process for the preparation and use of these compounds and compositions
EP0938901A4 (en)	2001-10-31	Medicinal compositions for treating liver diseases
AU4133997A (en)	1998-04-02	Pharmaceutical composition for the treatment of syndrome x of reaven
HUP9901434A3 (en)	2001-11-28	Substituted benzylamines and their use for the preparation of medicaments for treating depression
HUP9903684A3 (en)	2001-12-28	Use of olanzapine for the preparation of pharmaceutical compositions treating depression
HUP0103832A3 (en)	2002-12-28	Triazolopyridines for the treatment of thrombosis disorders, pharmaceutical compositions containing the same and process for preparation thereof
HUP0003679A3 (en)	2002-09-30	Use of pkc inhibitors for the preparation of pharmaceutical compositions treating cardiovascular diseases
HUP9903679A3 (en)	2001-10-29	Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder
IL119225A (en)	2000-09-28	Pharmaceutical compositions for the treatment of asthma in mammals
IL121096A0 (en)	1997-11-20	Pharmaceutical compositions for the treatment of liver disease
HUP9903688A3 (en)	2001-12-28	Use of olanzapine for the preparation of pharmaceutical compositions treating autism
IL128351A0 (en)	2000-01-31	Pharmaceutical composition for treating viral diseases
HUP0003159A3 (en)	2001-07-30	The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions